Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03380819 · ClinicalTrials.gov registry record · NA
The VetSeq Study: a Pilot Study of Genome Sequencing in Veteran Care
A NA study, sponsored by VA Boston Healthcare System.
- Completed
- Registry status
- NA
- Development phase
- 2
- Enrollment target
NCT03380819: Completed NA study, sponsored by VA Boston Healthcare System.
NCT03380819 is a NA study that has completed, run by VA Boston Healthcare System. The registered enrollment target is 2 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03380819, a NA study, has completed, sponsored by VA Boston Healthcare System.
- COMPLETED
- Registry status
- NA
- Development phase
- 2 participants
- Enrollment target
Study Summary
The VetSeq Study is a pilot intervention study exploring the feasibility of integrating genome sequencing into clinical care at the VA Boston Healthcare System.
Primary Outcome
Identification of a genetic variant that explains the patient's indication for sequencing
Interventions
- DIAGNOSTIC_TEST Genome sequencing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2017-12-29 |
| Est. Completion | 2022-12-31 |
| Phase | NA |
What the finished NCT03380819 record still lists
NCT03380819 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 2 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which Genome sequencing is the first listed.
NCT03380819 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03380819 about?
NCT03380819 is a clinical study titled "The VetSeq Study: a Pilot Study of Genome Sequencing in Veteran Care". The VetSeq Study is a pilot intervention study exploring the feasibility of integrating genome sequencing into clinical care at the VA Boston Healthcare System.
What is the current status of trial NCT03380819?
This trial is currently completed. It is a NA study. The enrollment target is 2 participants. The study started on 2017-12-29. Estimated completion is 2022-12-31.
What interventions are being tested in trial NCT03380819?
The interventions under investigation include: Genome sequencing (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03380819?
This trial is sponsored by VA Boston Healthcare System, which has 17 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03380819's enrollment target sits among peer trials
2 1997th of 2000 the lowest of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI